The cost of immunotherapy with Keytruda (Pembrolizumab) in Ukraine generally ranges from $4,500 to $8,000. Prices vary depending on the clinic, the oncologist’s experience, the number of treatment cycles, and whether Keytruda is combined with other therapies. In the United States, the average cost is $21,500 (per NCCN). That means immunotherapy with Keytruda in Ukraine can be about 71% less than in the U.S.
Ukrainian clinics usually include the cost of the Keytruda drug, oncologist consultations, infusion sessions, basic pre-treatment bloodwork, and routine follow-ups. In the U.S., drug costs, infusion fees, and lab work are often billed separately. Always confirm if extra tests, imaging, or supportive medications are covered in your treatment package.
| Ukraine | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | from $4,500 | from $3,300 | from $15,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. Abu Shamsiya Rami Nuamanovych is a specialist in general and laparoscopic surgery, oncology, and ultrasound diagnostics. He is a Candidate of Medical Sciences, an associate professor, and a doctor of the highest category. Dr. Nuamanovych is a member of the Ukrainian Association of Bariatric Surgeons and the World Organization of Bariatric Surgeons (IFSO).
He works as a WHO consultant on laparoscopic surgery. He is also President of the Association of Arab Doctors of Ukraine. Dr. Nuamanovych has performed thousands of surgeries, including hernia repairs, bariatric procedures, and cancer operations. His skills are recognized internationally. He speaks English and Arabic fluently.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.